Navigating Cardiotoxicity in Cancer Treatment: Insights into Fluoropyrimidine-induced Cardiac Events
The cardiotoxic event following 5-FU has been lesser-known clinical entity with limited study on its pathophysiology and management. In the diagnosis procedure, each patient undergoing FP treatment ought to have early symptom identity, risk categorization, and therapy individualized based on benefit-risk ratio.
Authors
- A.N. Rai (ORCID: https://orcid.org/0000-0002-7683-2706)
- Manodeep Chakraborty (ORCID: https://orcid.org/0000-0003-2691-1737)
- Ananya Bhattacharjee
- Mohammed K. Ali (ORCID: https://orcid.org/0000-0001-7266-2503)
- Ashika Bhattarai (ORCID: https://orcid.org/0000-0001-8310-0418)
- Chetiz Sharma
- Nihar Ranjan Bhuyan
- Rudra Acharya
- Yuan Rai
Institutions
- Himalayan University (IN)
Publication Details
- Journal
- Current Cardiology Reviews
- Published
- 2025-04-29
- DOI
- https://doi.org/10.2174/011573403x335593250413154832
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 0.00